Skip to main content
WCGIC 2023 Main banner
Back

Session III: Cancer of the Biliary Tract

Wednesday, June 28, 2023
17:35 – 18:55 CEST
Location:Auditorium A, Level 0

Presentations:

  • 17:35 – 17:55 CEST
    Locally Advanced Bile Duct Cancer: Criteria and Approaches in Borderline Resectable Disease

    Speaker: Thomas Gruenberger, MD – Clinic Favoriten, Dept Surgery, HPB Center, health network Vienna Sigmund Freud Private University Vienna

  • 17:55 – 18:05 CEST
    O-2: Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)

    Abstract Presenter: Jennifer Knox

  • 18:05 – 18:25 CEST
    Molecular Unraveling of Biliary Tract Cancer

    Speaker: Lipika Goyal, MD – Stanford School of Medicine

  • 18:25 – 18:35 CEST
    Debate: Are We Ready for Targeted Agents in First-Line Treatment of Advanced Biliary Tract Cancer Patients? - YES

    Debate Speaker: Tanios Bekaii-Saab, MD – Mayo Clinic

  • 18:35 – 18:45 CEST
    Debate: Are We Ready for Targeted Agents in First-Line Treatment of Advanced Biliary Tract Cancer Patients? - NO

    Debate Speaker: John Bridgewater, MD PhD – UCL Cancer Institute

  • 18:45 – 18:55 CEST
    Debate: Are We Ready for Targeted Agents in First-Line Treatment of Advanced Biliary Tract Cancer Patients? - DISCUSSION

    Panelist: Tanios Bekaii-Saab, MD – Mayo Clinic

    Speaker: John Bridgewater, MD PhD – UCL Cancer Institute